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1 Introduction
Prospective payment models, such as capitation, have a long history in the
financing of private and public sector health care. Capitated payments are
set at the expected total cost of a patient, which payors (e.g., employers or
Medicare) and recipients (e.g., health plans or Medicare HMOs) find mutu-
ally acceptable if those payments equal actual average cost (Maciejewski et
al, 2005). Problems arise if prospective payment models do not account for
distributional aspects of costs that can lead to significant deviations from
actual average costs, especially for particular populations or groups. Hence,
it is important to accurately predict the expected total cost of a patient over
a certain time period [0, τ ] after adjusting for patients’ characteristics. If
one is interested in median regression with censored cost data, see the paper
by Bang and Tsiatis (2002).
One of the main features in the distribution of health care costs that
can impede reliable prediction is its skewness due to the small percentage of
patients who invariably incur extremely high costs relative to most patients.
Recent efforts have yielded new statistical analysis methods that can adjust
for the special features in the distribution of health care costs (Zhou et al,
1997; Zhou and Tu, 1999; Zhou et al, 2001).
Censoring can also be a major issue in estimating the average lifetime
cost or cost in a certain time period. Censoring occurs when the complete
costs of some subjects in the certain time period for some subjects are not
available because the subjects are lost to follow-up before the end of the
study. If we only include uncensored subjects in analysis, we may underes-
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timate the average cost. This is because subjects who survive a long time
are likely to be censored and not included in analysis while subjects who die
early are likely to be uncensored and included in analysis. Subjects who die
shortly after entering a study often use the fewest resources whereas those
who remain alive for a long time are most likely to be expensive (Etzioni et
al, 1999).
The main challenge in the analysis of censored cost data is that the total
cost at the time of censoring is not independent of the total cost at the
time of death, even if the time of death and time of censoring are indepen-
dent. Hence, standard survival analysis techniques (e.g Cox models), which
assume independent censoring, cannot be directly used for the analysis of
censored costs data by treating censored costs as censored survival times.
For estimating the average cost of censored cost data without covariates, Lin
(1997), Bang and Tiastis (2000), and Jiang and Zhou (2004) proposed sev-
eral appropriate methods. For estimating the average cost of censored cost
data with covariates, Lin (2000a, 2000b, 2003) proposed several regression
models.
The existing regression models for incomplete cost data focus mostly
on finding consistent and asymptotically normal estimators for the individ-
ual components of the vector of regression parameters (β). However, the
expected total cost of a patient with a vector of given covariates is a com-
plicated function of β.
Although it is possible to derive confidence intervals for the expected
total cost of a patient over a certain period based on the asymptotical nor-
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mality of the estimator for β, there may be several problems with these kinds
of the confidence intervals. First, the normal approximation can have poor
coverage accuracy if the distribution of data is skewed, which is common for
cost data. Second, as it is well known in the literature, the confidence region
of the multi-dimensional parameter β, based on the normal approximation,
can have poor coverage accuracy even if the coverage probabilities for the
univariate components of β are close to the nominal level.
Empirical likelihood (EL) methods are popular non-parametric methods
for constructing confidence intervals and bands. As previously demonstrated
(Owen, 2001), an EL method has several advantages over the normal ap-
proximation method in constructing confidence bands and intervals. First,
EL methods do not assume a symmetrical shape, as is assumed in the nor-
mal approximation method; instead its shape is determined by data, and
the EL regions are Bartlett correctable in most cases (DiCiccio et al., 1991).
Hence, the EL-based method is especially suitable for skewed data. Second,
EL methods allow for confidence band construction without an informa-
tion/variance estimator. Third, the EL methods allow us to employ likeli-
hood methods without having to pick a parametric family for the data. In
this paper, we develop a new EL based confidence region for β and intervals
for the expected total cost over the period [0, τ ].
2 Data Setup and regression models
In this section, we use regression models for the mean of cost over the period
[0, τ ] and for the survival time. We follow the notation used in Lin (2003).
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For patient i (i = 1, ..., n), let Yi(t) be the total cost of the patient up to
time t. We can only observe Yi(t) at a finite number of possible time points,
t0, . . . , tK = τ . Let yki be the total cost over the kth (k = 1, ...,K) interval
[tk−1, tk), where t0 = 0 and tK = τ . That is, yki = Yi(tk)− Yi(tk−1). Then,
the total cost accumulated by the patient i over the entire interval [0, τ) is
Yi =
∑K
k=0 yki. Let Ti and Ci be the survival and censoring times of patient
i, respectively. Let Zi(t) be the p × 1 vector of potentially time-dependent
covariates for patient i. Denote Zki to be the value of Zi(t) when t is in
the kth interval. Since we take a position that no additional cost can be
accumulated after death, we have Yi(t) = Yi(t ∧ Ti). To model the effect of
covariates Z on the marginal distribution of yki, we use the same model as
in Lin (2003),
E(yki|Zki) = g(β′Zki), k = 1, ...,K; i = 1, ..., n, (1)
where g is some link function. This model includes both the previously pro-
posed linear regression model and the proportional mean model for censored
medical cost (Lin, 2000a, Lin, 2000b).
3 An Existing Estimation Procedure
In the presence of censoring, not all the yki’s are observable. Let T ∗ki =
min(tk, Ti), δ∗ki = I(T
∗
ki ≤ Ci), Xi = min(Ti, Ci), and δi = I(Ti ≤ Ci). So,
yki is observable if and only if δ∗ki = 1. Define Fi = {I(Ti ≤ t), Yi(t), L¯i(t)},
where L¯i(t) represents all the measured covariate processes, and H¯(t) =
{H(s) : s ≤ t} for any process H(.). Let G(t | F¯i) = P (Ci > t | F¯i(Ti)). Lin
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(2003) proposed the following generalized estimating equation for β:
Û(β) ≡
n∑
i=1
K∑
k=1
δ∗ki
Ĝ(T ∗ki | F¯i)
h(Zki;β)(yki − g(β′Zki))Zki = 0,
where h(Zki;β) is a given scalar function. From the theory of estimating
equations, we know that an optimal choice of h(Zik;β) is given by
h(Zik;β) = g(1)(β′Zik)/var(yki).
However, since var(yki) is unknown, we let the weight function h(Zik;β)
be 1 in the analysis presented in this article, although more general choices
are possible. Misspecification of the weight function will not affect the con-
sistency of the resulting estimator, only the efficiency. Here Ĝ(· | Fi) is a
consistent estimator of G(· | Fi). In the case of completely random cen-
soring, we may set Ĝ(· | F¯) to be the Kaplan-Meier estimator Ĝ(·) for the
common survival function of Ci. Otherwise, we take Ĝ(· | Fi) to be the
Breslow (1972) estimator, defined by
Ĝ(· | F¯i) = exp
− n∑
j=1
δ¯iI(Xj < t)eγ̂
′Wi(Xj)
S(0)(Xj ; γ̂)
 ,
where Wi(t) is a vector of known function of Fi, δ¯i = 1 − δi, and γ̂ is the
maximum partial likelihood estimator of the regression parameters in the
proportional hazards model (Cox, 1972)
λ(t | F¯i) = λ0(t)eγ̂′Wi(t), i = 1, ..., n,
and
S(ρ)(t; γ) =
n∑
i=1
I(Xi ≥ t)eγ′W
⊗ρ
i (t), ρ = 0, 1, 2.
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Here and in the sequel, we adopt the notation: a⊗0 = 1, a⊗1 = a, and
a⊗2 = aa′.
The solution β̂ to the above estimating equation is defined as an estima-
tor of β. Lin (2003) obtained the limiting distribution of β̂:
√
n(β̂ − β) L−→ N(0, A−1V A−1), (2)
where A = − limn→∞ n−1E(∂Û(β)∂β ), and V is given by (5) on Page 9 when
we discuss our EL method.
4 Empirical likelihood confidence region for β
In this section we propose EL-based confidence region for β. Let
Di =
K∑
k=1
δ∗ki
G(T ∗ki | F¯i)
h(Zki;β)(yki − g(β′Zki))Zki
and
D̂i =
K∑
k=1
δ∗ki
Ĝ(T ∗ki | F¯i)
h(Zki;β)(yki − g(β′Zki))Zki.
First consider the testing problem,
H0 : β = β0 vs. H1 : β 6= β0.
Since E(Di) = 0 for all i = 1, ..., n, the problem of testing whether β0 is
the true parameter of β is equivalent to testing whether EU(β0) = 0, where
U(β0) =
∑n
i=1Di.
This can be done by using Owen’s EL method (1990, 1991). Let p =
(p1, · · · , pn) be a probability vector, i.e.,
∑n
i=1 pi = 1 and pi ≥ 0 for all i.
Then, the empirical likelihood, evaluated at the true parameter value β0, is
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defined by
L˜(β0) = sup
{
n∏
i=1
pi :
n∑
i=1
pi = 1,
n∑
i=1
piDi = 0
}
.
Since Di’s depend on G(· | F¯i), which is unknown, replacing Di by D̂i, we
obtain the estimated empirical likelihood for β0:
L(β0) = sup
{
n∏
i=1
pi :
n∑
i=1
pi = 1,
n∑
i=1
piD̂i = 0
}
.
Then, by the Lagrange multiplier, we can easily get
pi =
1
n
{
1 + λ′D̂i
}−1
, i = 1, · · · , n,
where λ = (λ1, · · · , λp)′ is the solution of
1
n
n∑
i=1
D̂i
1 + λ′D̂i
= 0. (3)
Note that
∏n
i=1 pi, subject to
∑n
i=1 pi = 1, attains its maximum n
−n at
pi = n−1. So we define the empirical likelihood ratio at β0 by
R(β0) =
n∏
i=1
(npi) =
n∏
i=1
{1 + λ′D̂i}−1.
Therefore, the corresponding empirical log-likelihood ratio can be defined as
l(β0) = −2 logR(β0) = 2
n∑
i=1
log{1 + λ′D̂i}, (4)
where λ = (λ1, · · · , λp)′ is the solution to Equation (3).
Before introducing the main theorem, we need some additional notation.
If censoring occurs in a completely random fashion, we define
ηi =
∫ ∞
o
q(t)dMi(t),
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where
Mi(t) = δ¯iI(Xi ≤ t)−
∫ t
0
I(Xi ≥ x)λ(x)dx,
λ(x) = −d logG(x)
dx
, and
q(t) = lim
n→∞n
−1
n∑
i=1
K∑
k=1
δ∗kiI(T
∗
ki > t)
G(T ∗ki | F¯i)P (Xi ≥ t)
h(Zki;β)(yki − g(β′Zki))Zki.
Otherwise, we define
ηi =
∫ ∞
0
[
q(t) + bΩ−1 (Wi(t)− w¯(t))
]
dMi(t),
where
Mi(t) = δ¯iI(Xi ≤ t)−
∫ t
0
I(Xi ≥ x)eγ′Wi(t)λ0(x)dx,
q(t) = lim
n→∞n
−1
n∑
i=1
K∑
k=1
δ∗kiI(T
∗
ki > t)e
γ′Wi(t)
Ĝ(T ∗ki | F¯i)s(0)(t)
h(Zki;β)(yki − g(β′Zki))Zki,
s(ρ)(t) = lim
n→∞n
−1S(ρ)(t) (ρ = 0, 1, 2),
b = lim
n→∞n
−1
n∑
i=1
K∑
k=1
δ∗ki
Ĝ(T ∗ki | F¯i)
h(Zki;β)(yki − g(β′Zki))Zkir′(T ∗ki;Wi),
r(t;W) =
∫ t
0
eγ
′W(x) [W(x)− w¯(x)]λ0(x)dx,
w¯(t) = s(1)(t)/s(0)(t),
Ω =
∫ ∞
0
[
s(2)(t)/s(0)(t)− w¯⊗2(t)
]
s(0)(t)λ0(t)dt.
Let
V1 = lim
n→∞n
−1
n∑
i=1
D⊗2i and V = limn→∞n
−1
n∑
i=1
(Di + ηi)
⊗2 . (5)
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The following conditions are needed in this paper:
C1. q(t) <∞ and s(ρ)(t) <∞ (ρ = 0, 1, 2) for every t.
C2. ‖b‖ <∞ and ‖Ω‖ <∞.
C3. V1 and V are positive definite matrix.
C4. maxk,i
∥∥∥ δ∗ki
G(T ∗ki|F¯i)
h(Zki;β)(yki − g(β′Zki))Zki
∥∥∥ = op(n1/2).
Theorem 1. Assume the conditions C1-C4 hold. If β0 is the true
value of β, then l(β0) has the asymptotical distribution as a weighted sum of
independent chi-square random variables with 1 degree of freedom; that is,
l(β0)
L−→ l1χ21,1 + · · ·+ lpχ2p,1,
where χ2i,1’s, for 1 ≤ i ≤ p, are independent chi-square random variables with
one degree of freedom, and the weights li, 1 ≤ i ≤ p, are the eigenvalues of
V −11 V .
We provide a proof of Theorem 1 in the Appendix. In order to apply
Theorem 1, we first need to estimate the weights li, 1 ≤ i ≤ p. To estimate
the weights, we define
η̂i = δ¯iQ(Xi)−
n∑
j=1
δ¯jI(Xj ≤ Xi)Q(Xj)∑n
l=1 I(Xl ≤ Xj)
, if Ĝ is the Kaplan-Meier estimator,
where
Q(t) =
n∑
i=1
K∑
k=1
δ∗kiI(T
∗
ki > t)h(Zki; β̂)(yki − g(β̂′Zki))Zki
Ĝ(T ∗ki)
/
n∑
j=1
I(Xj ≥ t)
or
η̂i = δ¯iNi(Xi)−
n∑
j=1
δ¯jI(Xj ≤ Xi)eγ̂′Wi(Xj)Ni(Xj)
S(0)(Xj ; γ̂)
, if Ĝ is the Breslow estimator.
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Here
Ni(t) = Q˜(t) +BΩ̂−1
[
Wi(t)− S(1)(t; γ̂)/S(0)(t; γ̂)
]
,
Q˜(t) =
n∑
i=1
K∑
k=1
δ∗kiI(T
∗
ki > t)e
γ̂′Wi(t)
Ĝ(T ∗ki | F¯i)S(0)(t; γ̂)
h(Zki; β̂)(yki − g(β̂′Zki))Zki,
B = n−1
n∑
i=1
K∑
k=1
δ∗ki
Ĝ(T ∗ki | F¯i)
h(Zki; β̂)(yki − g(β̂′Zki))ZkiR′(T ∗ki;Wi),
R(t;W) =
n∑
i=1
δ¯iI(Xi < t)eγ̂
′W(Xi)
[
W(Xi)− S
(1)(Xi; γ̂)
S(0)(Xi; γ̂)
]/
S(0)(Xi; γ̂) , and
Ω̂ =
n∑
i=1
δ¯i
[
S(2)(Xi; γ̂)
S(0)(Xi; γ̂)
− S
(1)(Xi; γ̂)⊗2
S(0)(Xi; γ̂)2
]
.
Then we can consistently estimate V1 and V by
V̂1 = n−1
n∑
i=1
D˜⊗2i , (6)
V̂ = n−1
n∑
i=1
(
D˜i + η̂i
)⊗2
, (7)
respectively, where
D˜i =
K∑
k=1
δ∗ki
Ĝ(T ∗ki | F¯i)
h(Zki; β̂)(yki − g(β̂′Zki))Zki.
Here the estimator V̂ of V is the same as the one given in Lin (2003). Hence
li, 1 ≤ i ≤ p can be consistently estimated by the eigenvalues l̂i’s of V̂ −11 V̂ .
Confidence regions for β can be constructed as follows. Let
Rα(β) = {β : l(β) ≤ cα}, (8)
where cα is the Monte Carlo approximation to the (1 − α)th quantile of
the weighted chi-square distribution l1χ21,1 + · · · + lpχ2p,1. Then from the
11
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earlier discussion, Rα(β) gives an approximate confidence region of β with
asymptotically correct coverage probability 1− α, i.e.,
P (β0 ∈ Rα(β)) = 1− α+ o(1).
Note that Monte Carlo simulation is needed to calculate the critical value
cα in (8). This can be done by first generating a large number of realizations
of l̂1χ21,1+· · ·+ l̂pχ2p,1 and then taking cα to be the (1−α)-th sample quantile.
Next we describe another method for constructing a confidence region
of β without resorting to Monte Carlo simulation. Define
rn(β) =
tr(V̂ −1Sn)
tr(V −11n Sn)
,
where
V1n =
1
n
n∑
i=1
D̂iD̂
′
i, Sn =
( 1√
n
n∑
i=1
D̂i
)( 1√
n
n∑
i=1
D̂i
)′
,
and V̂ is defined by equation (7) in Section 4. Then, by examining the proof
of Theorem 1 (see Appendix), we have
rn(β)l(β)
L−→ r(β)
p∑
i=1
liχ
2
i,1, as n→∞,
where r(β) = p/tr(V −11 V ) with tr(·) denoting the trace operator. Rao
and Scott (1981) showed that the distribution of r(β)
∑p
i=1 liχ
2
i,1 could be
approximated by the standard χ2p distribution. Therefore, an approximate
1− α confidence region of β0 can be constructed as follows:
{β : rn(β)l(β) ≤ χ2p(α)}, (9)
where χ2p(α) is the (1− α)-th quantile of the standard χ2p distribution. It is
worth noting that the adjustment factor rn(β) can be motivated from the
12
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fact that r(β) can be rewritten as r(β) = tr(V −1V )/tr(V −11 V ), replacing
V −1, V −11 and V by V̂
−1, V −11n and Sn respectively leads to rn(β).
Before we end this section, we remark that when there is no censoring
in the observations, ηi = 0 for i = 1, ..., n, and l(β0)
L−→ χ2p. So Theorem 1
reduces to the Wilks’ theorem in the context of generalized linear regression
models.
5 Empirical likelihood based intervals for the ex-
pected total costs
Let zk0 and yk0 be the covariate value and the total cost of a patient at
the kth interval [tk, tk+1), where k = 1, . . . ,K. Then, the total cost of
this patient over the entire interval [0, τ) is Y0 =
∑K
k=1 yk0. We want to
construct a confidence interval for u0 =
∑K
k=1E(yk0 | zk0). Based on the
assumed generalized linear model in Section 2, we obtain an expression for
u0 as follows:
u0 =
K∑
k=1
g(β′zk0). (10)
Let R be the (1−α)100% empirical likelihood based confidence region for β,
as defined in (9). Then, we can obtain a confidence interval for the expected
cost u0 of a patient with z = (z01, . . . , z0K)′ as follows:
{µ(z) =
K∑
k=1
g(β′zk0) : β ∈ R}. (11)
This confidence interval has the coverage probability that is greater than or
equal to 1− α with the equality achieved when g(.) is an one-one function.
13
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6 Numerical studies
We carried out two simulation studies to compare the finite-sample prop-
erties of our proposed method with the method of Lin (2003). Since the
confidence interval for the expected cost u0 is determined by the confidence
region of β, in the simulation studies we focus on the coverage accuracy of
the confidence regions of β.
In the first simulation, we adopt a similar parameter set-up as in Lin
(2003). Survival and censoring times are generated from the exponential
distribution with mean m and uniform (0, c) distribution, respectively. The
combinations of (m, c) = (5, 40), (5, 20), and (10, 20) yield the mean censored
rate of approximately 12.6%, 24.4%, and 43.2%, respectively. We divide the
entire study period into three equally spaced intervals. We set
yki =
[
I(k = 1)udi + I(Ti > tk)(²i + uki)
+I(tk−1 < Ti ≤ tk){(²i + uki)(Ti − tk−1) + ufi }
]
exp(ξZi)
for k = 1, 2, 3; i = 1, · · · , n, where ²i, uki, udi and ufi are independent ran-
dom variables with uniform distributions. Specifically, ²i and uki have the
uniform (0, 1) distribution, udi and u
f
i have the uniform (0, 5) and (0, 10)
distributions, respectively. This scheme creates J-shaped time patterns. For
the same subject, the costs in different intervals share a common random
effect and are thus positively correlated. It is easy to see that the cost data
satisfy
E[yki|Zi] = µk exp{ξZi}
14
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So, β = (ξ, µ1, µ2, µ3), µk is the mean cost in time (k − 1, k] for the sub-
ject with the covariate Z = 0. We choose two different sets of values for
(m,u1, u2, u3): (5, 4.313, 1.484, 1.215), and (10, 3.928, 1.292, 1.1689). We set
Z to be a treatment indicator with n/2 subjects in each of the two groups
and ξ to be 1. We choose n = 100, 200 and 500 as in Lin (2003). We sum-
marize the results from 500 repetitions in Table 1 along with the coverage
accuracy of the confidence regions for β using our method and the normal
approximation method based on Lin’s approach. Our results for ξ are very
similar to those reported in Lin (2003), and hence are not reported in Table 1
as our focus is on β.
Table 1 goes here
In Table 1, EL.CP is the coverage probability of the 95% nominal level
confidence region for β, based on the empirical likelihood method. The CP
is the coverage probability of the 95% nominal level confidence region for β,
based on the normal approximation of β̂, given in Lin (2003), and defined
by
n(β̂ − β)T (Â−1V̂ Â−1)−1(β̂ − β) ≤ χ2p(α), (12)
where Â and V̂ are consistent estimators of A and V respectively (see also
(2) in Section 3). From Table 1 we see that both the empirical likelihood
and normal approximation methods yield the confidence regions for β that
are close to the nominal level, and the empirical likelihood method is slightly
better than the normal approximation method for heavy censoring.
15
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Since generated cost observations in Table 1 above are from some uni-
form distributions, the resulting cost data have an approximately normal
distribution. In fact, simulation studies done in Lin’s papers (2000a, 2000b,
2003) assumed that cost data followed a normal distribution. However, as
we know from the literature (Zhou et al, 1997; Jiang and Zhou, 2004), cost
data are not normally distributed but instead are skewed. In the second
simulation study, we generate cost data from a skewed distribution. This
simulation study is similar to the first one, except that covariates are gen-
erated from a normal distribution N(ν, σ2), where ν = 2, σ is chosen to be
1 and 2, and the coefficient ξ was chosen to be 0.1, 0.2, 0.4, and 0.6. Under
this setup, the distribution of the total medical cost of a patient becomes
more skewed as σ and ξ increase.
The results with a fixed sample size of 100 from 500 repetitions are
summarized in Table 2. With lightly skewed cost data, the improvement
in the coverage accuracy of the empirical likelihood based confidence re-
gion is minimal compared to the one based on the normal approximation
confidence region. But when the skewness increases, the improvement is no-
ticeably significant, and the coverage probability of the empirical likelihood
based confidence region is much closer to the nominal level than the normal
approximation confidence region.
Table 2 goes here
Numerical studies are also conducted at a larger sample size under the
same simulation scheme as in Table 2. Table 3 shows a comparison of the two
types of confidence regions with n = 400. As the sample size increases, the
16
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performance of both types of confidence regions improve; however, the cov-
erage probabilities from the normal approximation approach are still much
lower than the nominal level when the cost distribution is severely skewed.
The empirical confidence region has the better and more robust performance
than the normal approximation approach for all the cases considered here.
Table 3 goes here
In summary, the accuracy of the EL-based confidence regions and the
normal approximation based regions for β are close when data is less skewed.
When cost data are highly skewed, which are likely to occur in practice, the
EL-based confidence regions greatly outperform the normal approximation
method although there is still room for further improvement.
7 A real data example
To illustrate the application of our methodology, we use the same SEER
Medicare database as in Lin (2003). Our data consist of 985 and 2647 pa-
tients diagnosed with regional and distant stages of epithelial ovarian cancer,
respectively. The data on survival time and monthly medical expenditures
are available from 1983 to 1990. The subjects who were still alive at the end
of 1990 are censored. There is no voluntary loss to follow-up in this study,
so that censoring, which is solely caused by limited study duration, can be
regarded as completely random. Thus, the proposed methods with Ĝ as the
Kaplan-Meier estimator can be used. Since most of the patients did not
survive to the 7th year, we confine our attention to the first 6 years after
the diagnosis. The focus of our analysis is to provide a confidence interval
17
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for the expected total cost of a patient during the first 6 years after the first
diagnosis of cancer, using the given covariates of the patient.
From Figure 4 in Lin (2003), we see that the effects of the stages on the
cost are not constant over time on either an additive or multiplicative scale.
So, we compute the expected total cost on [0, τ ] separately for regional and
distant groups. To illustrate the proposed methodology, we also include a
continuous covariate Z, the time of the first diagnosis, in the model, where
Z = 0 corresponds to a new cancer patient. We are interested in constructing
a confidence interval for the expected total cost over [0, τ ] for a patient with
Z = z, where τ = 72 months. Let Y0 be the total cost over [0, τ ] of a
patient with Z = z0. Then, we like to construct a 95% confidence interval
for u0 = E(Y0 | Z = z0).
Let yki denote the total cost over the kth month for patient i, k =
1, . . . , τ = 72, and let Zi be the value of Z for the ith patient. We fit
a separate generalized linear model for patients with regional stages and
patients with distant stages, respectively. The fitted model has the following
general form:
E(yki|Zi) = µk exp{ξZi},
where k = 1, . . . , τ = 72. Since there is no closed form for the confidence
interval of the expected total cost when the empirical likelihood method is
used, we propose a numerical method to determine the EL-based confidence
interval. Note that the expected total cost over [0, τ ] is
∑τ
k=1 µk exp{ξz}
when Z = z and that the univariate empirical likelihood confidence region is
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always an interval. Let β = (ξ, µ1, · · · , µτ )T , and R be the 95% confidence
region for β. Then, we can write the EL-based confidence interval for the
expect total cost on (0, τ) as (q0, q1), where
q0 = min
{
τ∑
k=1
µk exp{ξz} : β ∈ R
}
,
and q1 = max
{
τ∑
k=1
µk exp{ξz} : β ∈ R
}
.
From (8), we know that we can write q0 and q1 as
q0 = min{
τ∑
k=1
µk exp{ξz} : l(β) = c, 0 ≤ c ≤ cα}
≈ min{∪Ni=1{
τ∑
k=1
µk exp{ξz} : l(β) = ci}} for large N,
q1 = max{
τ∑
k=1
µk exp{ξz} : l(β) = c, 0 ≤ c ≤ cα}
≈ max{∪Ni=1{
τ∑
k=1
µk exp{ξz} : l(β) = ci}} for large N,
where {c1, . . . , cN} is a random sample of size N generated from the uniform
distribution over [0, cα]. Therefore, for estimating q0 and q1, we need to
solve the equation l(β) = c for any c ∈ [0, cα]. Tian et al. (2003) proposed
a numerical algorithm for a similar problem, but their method requires an
initial approximation solution for the equation l(β) = c which is difficult
to obtain in our case. Therefore, we propose a nonparametric technique to
solve l(β) = c. First, we note that it is feasible to compute l(β) for any
given β and that R may be approximated by R0, which is defined by
R0 = {β : µˆk − 1.96σˆk ≤ µk ≤ µˆk + 1.96σˆk, k = 1, · · · , τ,
and ξˆ − 1.96σˆ ≤ ξ ≤ ξˆ + 1.96σˆ
}
,
19
http://biostats.bepress.com/uwbiostat/paper270
where σˆk is the estimator of the standard error of µˆk, k = 1, · · · , τ and σˆ is
the estimator of the standard error of ξˆ. By generating J vectors β(j), j =
1, · · · , J uniformly over R0 that satisfy l(β)(j) ≤ cα, we can estimate β
which satisfies l(β) = c for any given c ∈ [0, cα] by a smoothing technique
(for example, local linear or spline) based on data (β(j), l(β(j))), j = 1, · · · , J ,
where the value of J depends on the number of parameters. In our example,
for τ = 12, since the number of the parameters is 13, we take J = 1000
because the results do not change significantly as J is chosen to be greater
than 10000. Similarly, for τ = 24, we choose J = 2000, and for τ = 72, we
choose J = 20000.
In Tables 4 and 5, we report the 95% confidence interval for u0 = E(Y0 |
Z = z0) when z0 = 0. The EL-based confidence interval is wider than the
interval based on the normal approximation. The result is consistent with
our simulation results which have shown that the normal approximation
interval has a coverage probability that is lower than the nominal level while
the EL based interval has a coverage probability that is close to the nominal
level.
Tables 4 and 5 go here
8 Discussion
In this paper we develop an empirical likelihood (EL) based interval estima-
tion method for the expected total cost of a patient with given covariates
over a certain period when costs of some patients were censored. The is-
sue of correctly predicting such an expected cost has important implications
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in health economics, especially in prospective payment systems. We have
also developed the underlying asymptotic theory for the proposed EL-based
method and conducted a simulation study to compare its performance with
the existing method in finite-sample sizes. Our simulation results show
that the proposed EL-based method performs equally well with the exist-
ing method when cost data are not so skewed, and outperforms the existing
method when cost data are moderately or highly skewed in terms of coverage
accuracy in almost all cases.
Since in almost all cost studies, cost data are skewed, and many of them
have the skewness of greater than 1.0 and a sample size between 100 and
4000 (see Katon et al (2004) and Liu et al (2003)), we believe that our new
method has more practical relevance that the existing method.
The EL have better coverage probability than the direct normal ap-
proximation, which is a phenomenon happened in many applications of EL
methods. For example, see Qin and Jing (2001); Qin and Tsao (2003); Li
and Wang(2003); Wang, Linton, and Hrdle(2004) among others. The fu-
ture research will be in the direction of finding the edgeworth expansion
for the coverage probability of EL intervals, which may shed some light on
why EL method having better coverage accuracy than the direct normal
approximation.
As noticed by the referee, the EL confidence intervals can have poor
coverage, which occur when the data is seriously skewed. A future research
direction is to see whether we can obtain better intervals if we can find
a transformation that can transform the original data into less skewed or
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almost symmetric data before we apply our EL method.
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Appendix. Proof of Theorem 1
We need a few lemmas for proving Theorem 1.
Lemma 1. (See Lin, 2003)
1√
n
n∑
i=1
D̂i
L−→ N(0, V )
Lemma 2. We have the following properties for D̂i.
(i) max
i
‖D̂i‖ = op(n1/2) (ii) 1
n
n∑
i=1
D̂iD̂′i
p−→ V1.
Proof of the Lemma 2.
(i). From the condition C4, we have
max
i
‖Di‖ = op(n1/2).
Using the uniform consistency of Kaplan-Meier estimator and Breslow esti-
mator, we get
D̂i −Di =
K∑
k=1
Ĝ(T ∗ki | F¯i)−G(T ∗ki | F¯i)
G(T ∗ki | F¯i)Ĝ(T ∗ki | F¯i)
δ∗kih(Zki;β)(yki − g(β′Zki))Zki(13)
= op(1)
uniformly for i = 1, ..., n. So,
max
i
‖D̂i‖ ≤ max
i
‖D̂i −Di‖+max
i
‖Di‖ = op(n1/2)
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(ii) Let V˜1 = 1n
∑n
i=1DiD
′
i. Note that V1n =
1
n
∑n
i=1 D̂iD̂
′
i. For any
a ∈ Rp, we have the following decomposition:
a′
(
V1n − V˜1
)
a =
1
n
n∑
i=1
(
a′(D̂i −Di)
)2
+
2
n
n∑
i=1
(a′Di)
(
a′(D̂i −Di)
)
≤
(
1√
n
n∑
i=1
|a′(D̂i −Di)|
)(
1√
n
max
i
|a′(D̂i −Di)|+ 2√
n
max
i
|a′Di|
)
≡ J0(J1 + 2J2). (14)
From the proof of (i), we obtain that J1 = op(1) and J2 = op(1). Now
let’s look at the term J0. If the Kaplan-Meier estimator Ĝ is used as the
estimator of G, using (13) and the following martingale representation for
Ĝ,
n1/2(G(t)− Ĝ(t))
G(t)
= n−1/2
n∑
j=1
∫ t
0
dMj(x)
P (Xj ≥ x) + op(1),
we have
J0 =
∣∣∣∣∣∣n−1/2
n∑
j=1
∫ ∞
0
q1(t)dMj(t)
∣∣∣∣∣∣+ op(1)
= Op(1) + op(1) = Op(1),
where
q1(t) = lim
n→∞n
−1
n∑
i=1
∣∣∣∣∣
K∑
k=1
δ∗kiI(T
∗
ki > t)
Ĝ(T ∗ki | F¯i)P (Xi ≥ t)
h(Zki;β)(yki − g(β′Zki))(a′Zki)
∣∣∣∣∣
Similarly, if we use the Breslow estimator Ĝ(t | F¯) of G(t | F¯), using (13)
and the following representation due to Lin, Fleming and Wei (1994), we
obtain that
n1/2
(
G(t | F¯)− Ĝ(t | F¯)
)
G(t | F¯) = n
−1/2
n∑
j=1
∫ t
0
eγ
′W(x)dMj(x)
s(0)(x)
+r′(t;W)Ω−1n−1/2
n∑
j=1
∫ ∞
0
[Wj(x)− w¯(x)] dMj(x) + op(1).
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Hence we can also get J0 = Op(1). Therefore V1n = V˜1 + op(1), and Lemma
2(ii) is thus proved.
Proof of Theorem 1. Applying Taylor’s expansion to (4), we get
l(β0) = 2
n∑
i=1
log{1 + λ′D̂i} = 2
n∑
i=1
(
λ′D̂i − 12(λ
′D̂i)2
)
+ rn, (15)
where
|rn| ≤ C
n∑
i=1
(λ′D̂i)3 in probability.
Write λ = κθ, where κ ≥ 0 and ‖θ‖ = 1. From the proof of Lemma 2(ii),
we get
θ′V1nθ = θ′V˜1θ + op(1).
Then, using Lemma 1, Lemma 2(ii), and the argument similar to the one in
Owen (1990), we can show that
‖λ‖ = Op(n−1/2). (16)
Hence, using (16) and Lemma 2 together we obtain
|rn| ≤ C‖λ‖3 max
1≤i≤n
‖D̂i‖
n∑
i=1
‖D̂i‖2 = op(1). (17)
Note that
1
n
n∑
i=1
D̂i
1 + λ′D̂i
=
1
n
n∑
i=1
D̂i
[
1− λ′D̂i + (λ
′D̂i)2
1 + λ′D̂i
]
=
1
n
n∑
i=1
D̂i −
(
1
n
n∑
i=1
D̂iD̂′i
)
λ+
1
n
n∑
i=1
D̂i
(
λ′D̂i
)2
1 + λ′D̂i
.
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From (3), (16), and Lemma 2, it follows that
λ =
(
n∑
i=1
D̂iD̂′i
)−1 n∑
i=1
D̂i + op(n−1/2). (18)
Again by (3), we get that
0 =
n∑
i=1
λ′D̂i
1 + λ′D̂i
=
n∑
i=1
(λ′D̂i)−
n∑
i=1
(λ′D̂i)2 +
1
n
n∑
i=1
(λD̂′i)
3
1 + λ′D̂i
. (19)
By (16) and Lemma 2, we obtain
1
n
n∑
i=1
(λ′D̂i)3
1 + λ′D̂i
= op(1). (20)
From (19) and (20), we get
n∑
i=1
λ′D̂i =
n∑
i=1
(λ′D̂i)2 + op(1). (21)
By (15), (17), (18) and (21), we get
l(β0) =
n∑
i=1
λ′D̂iD̂′iλ+ op(1)
=
(
n−1/2
n∑
i=1
D̂i
)′(
n−1
n∑
i=1
D̂iD̂′i
)−1(
n−1/2
n∑
i=1
D̂i
)
+ op(1)
=
(
V −1/2n−1/2
n∑
i=1
D̂i
)′ (
V 1/2V −11 V
1/2
)(
V −1/2n−1/2
n∑
i=1
D̂i
)
+ op(1).
Then Theorem 1 directly follows from Lemma 1, Lemma 2(ii) and Lemma
5 in Qin and Jing (2001).
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Table 1: Coverage accuracy of confidence regions for β with the symmetric
distribution
m c n censored rate CP EL.CP
5 40 100 0.126 0.916 0.913
200 0.922 0.920
500 0.942 0.932
5 20 100 0.244 0.902 0.911
200 0.920 0.918
500 0.938 0.938
10 20 100 0.432 0.916 0.929
200 0.928 0.936
500 0.938 0.938
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Table 2: Simulation results for the asymmetric distribution(n = 100)
censored β
m c rate σ ξ Skewness CP EL.CP
5 40 0.1256 1 0.1 0.7841 0.9128 0.9226
2 0.1 0.9763 0.8887 0.9085
1 0.2 0.9763 0.8800 0.8972
2 0.2 1.5151 0.7816 0.8360
1 0.4 1.5151 0.7800 0.8283
2 0.4 2.7259 0.5000 0.7419
1 0.6 2.1101 0.6480 0.7445
2 0.6 3.9317 0.2773 0.6721
5 20 0.2444 1 0.1 0.7841 0.9063 0.9163
2 0.1 0.9763 0.8864 0.9106
1 0.2 0.9763 0.8760 0.8994
2 0.2 1.5151 0.7711 0.8421
1 0.4 1.5151 0.7680 0.8347
2 0.4 2.7259 0.4900 0.7425
1 0.6 2.1101 0.6600 0.7404
2 0.6 3.9317 0.2872 0.6755
10 20 0.4318 1 0.1 1.0155 0.9047 0.9165
2 0.1 1.1760 0.8763 0.8925
1 0.2 1.1760 0.8700 0.8880
2 0.2 1.6308 0.7856 0.8193
1 0.4 1.6308 0.7840 0.8096
2 0.4 2.7321 0.5140 0.7379
1 0.6 2.1592 0.6460 0.7264
2 0.6 3.9001 0.2990 0.6862
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Table 3: Simulation results for the asymmetric distribution(n = 400)
censored θ
m c rate σ ξ Skewness CP EL.CP
5 40 0.1247 1 0.1 0.8221 0.948 0.950
2 0.1 1.0491 0.952 0.952
1 0.2 1.0491 0.952 0.952
2 0.2 1.7364 0.920 0.920
1 0.4 1.7364 0.920 0.920
2 0.4 3.6446 0.700 0.832
1 0.6 2.6122 0.840 0.878
2 0.6 5.9674 0.458 0.734
5 20 0.2455 1 0.1 0.8221 0.936 0.940
2 0.1 1.0491 0.942 0.946
1 0.2 1.0491 0.942 0.946
2 0.2 1.7364 0.932 0.932
1 0.4 1.7364 0.932 0.928
2 0.4 3.6446 0.696 0.830
1 0.6 2.6122 0.846 0.886
2 0.6 5.9674 0.470 0.734
10 20 0.4334 1 0.1 1.0477 0.932 0.936
2 0.1 1.2323 0.924 0.932
1 0.2 1.2323 0.924 0.932
2 0.2 1.8215 0.916 0.926
1 0.4 1.8215 0.916 0.926
2 0.4 3.5986 0.724 0.829
1 0.6 2.6179 0.842 0.869
2 0.6 5.9025 0.450 0.723
Table 4: The average cost for the regional-stage patients in the first 6 years
τ average cost 95%CI(normal) 95%CI(EL)
12 31638.17 [30325.31, 32951.03] [28928.03, 35801.20]
24 45321.87 [43049.58, 47594.16] [40075.41, 51216.07]
36 56053.82 [52619.14, 59488.51] [49916.64, 60339.97]
48 63734.03 [59266.65, 68201.42] [56401.28, 74029.19]
60 71861.62 [66095.95, 77627.29] [63872.28, 84207.23]
72 77967.85 [71267.34, 84668.37] [70927.91, 89366.97]
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Table 5: The average cost for the distant-stage patients in the first 6 years
τ average cost 95%CI(normal) 95%CI(EL)
12 38028.34 [37007.67, 39049.00] [35195.77, 41972.41]
24 56373.66 [54557.11, 58190.21] [51378.09, 62906.75]
36 70895.30 [68057.08, 73733.51] [66108.69, 76880.35]
48 82330.58 [78034.04, 86627.12] [76459.93, 88756.02]
60 92018.35 [86056.14, 97980.55] [84334.12, 100357.07]
72 99249.84 [91981.43, 106518.24] [91162.97, 109599.23]
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